Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Gomille T, Meyer RA, Falkai P, Gaebel W, Konigshausen T, Christ F (2001) Prevalence and clinical significance of computerized tomography verified idiopathic calcinosis of the basal ganglia. Radiologe 41(2):205–10PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Perry CM, Wagstaff AJ (1995) Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections. Drugs 50:396–415PubMedGoogle Scholar

Literatur

  1. 1.
    Kyle RA, Dyck PJ (1993) Amyloidosis and neuropathy. In: Dyck PJ, Thomas PK (Hrsg) Peripheral neuropathy. WB Saunders Company, Philadelphia, pp 1294–1309.Google Scholar

Literatur

  1. 1.
    Commission on Classification and Terminology of the International League against Epilepsy (1989). Proposal for revised clinical and electroencephalographic classification of epileptic syndromes. Epilepsia 30:389–399.Google Scholar

Literatur

  1. 1.
    Schmidt D, Malin J-P (1986) Erkrankungen der Hirnnerven. Thieme, Stuttgart New York.Google Scholar

Literatur

  1. 1.
    Schmidt D, Malin J-P (1986) Erkrankungen der Hirnnerven. Thieme, Stuttgart New York.Google Scholar

Literatur

  1. 1.
    McDaris HL, Hutchinson J, on behalf of the Frovatriptan Phase III Investigators (1999) Frovatriptan-a review of overall clinical efficacy. 9th International Congress of the IHS, BarcelonaGoogle Scholar

Literatur

  1. 1.
    Ceballos-Baumann AO (1996). Medikamentös induzierte Bewegungsstörungen. In: Conrad B, Ceballos-Baumann AO (Hrsg.) Bewegungsstörungenin der Neurologie. Thieme, Stuttgart: 308–332.Google Scholar
  2. 2.
    Ceballos-Baumann AO (1999). Medikamenteninduzierte Dyskinesien. In: Berlit P (Hrsg.) Klinische Neurologie. Springer-Verlag 906–12.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Personalised recommendations